Wells Fargo
CINC

Wells Fargo’s CinCor Pharma, Inc. Common Stock CINC Stock Holding History

Wells Fargo’s Portfolio CINC Stock Details CINC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-46
Closed -$2K – 7853
2022
Q3 		$2K Sell
46
-121
-72% -$3.42K ﹤0.01% 6241
2022
Q2 		$3K Sell
167
-2,364
-93% -$45.3K ﹤0.01% 6265
2022
Q1 		$44K Buy
+2,531
New +$51.9K ﹤0.01% 5724

Other funds holding CINC

SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Wells Fargo's CINC Position: Q4 2022 in Review

Wells Fargo sold out of CinCor Pharma, Inc. Common Stock (CINC) in Q4 2022, closing a stake of 46 shares — an estimated $2K sold.

Wells Fargo first reported a position in CINC in Q1 2022 and held it in 3 quarters. The position peaked at $44K in Q1 2022. 102 funds tracked by Wall St. Rank hold CINC as of Q4 2022.

  • Wells Fargo reported no remaining CinCor Pharma, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Wells Fargo sold 46 CinCor Pharma, Inc. Common Stock shares in Q4 2022, an estimated $2K.
  • Wells Fargo first reported a position in CinCor Pharma, Inc. Common Stock in Q1 2022 and held it in 3 quarters.
  • Wells Fargo's CinCor Pharma, Inc. Common Stock position peaked at $44K in Q1 2022.
  • 102 funds tracked by Wall St. Rank held CinCor Pharma, Inc. Common Stock as of Q4 2022.

Based on Wells Fargo's 13F filing for Q4 2022, filed 13 Feb 2023.